{"id":"W4318262272","doi":"10.1016/j.ygyno.2023.01.021","title":"Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame","funders":"National Cancer Institute; Mayo Foundation for Medical Education and Research; Amgen; Mayo Clinic","keywords":"Medicine; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Internal medicine; Adverse effect; Progression-free survival; Phases of clinical research; Gastroenterology; Confidence interval; Oncology; Surgery; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003552369,0.00126451,0.002703682,0.0004726377,0.0004586065,0.001050131,0.0006559482,0.001113167,0.001565726],"category_scores_gemma":[0.001976701,0.0004509666,0.001935198,0.0004482339,0.001163067,0.001077333,0.0003188204,0.003614773,0.0004335949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008672324,"about_ca_system_score_gemma":0.001619876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001226222,"about_ca_topic_score_gemma":0.002877288,"domain_scores_codex":[0.9989527,0.0006019616,0.00007404522,0.0001342936,0.00009407821,0.0001428212],"domain_scores_gemma":[0.997858,0.0005607281,0.0004631777,0.0002026476,0.0001165761,0.0007988753],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7321803,0.0537932,0.02072009,0.000798638,0.005006551,0.0002878438,0.0005414154,0.004415723,0.03910403,0.0004251043,0.005064982,0.1376621],"study_design_scores_gemma":[0.4208962,0.5161307,0.04787364,0.00005482327,0.002379081,0.0005716315,0.0001504495,0.002733395,0.005355881,0.0003294925,0.003454414,0.0000702192],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915872,0.003542531,0.0006099184,0.0004009432,0.000115384,0.0007846841,0.001220139,0.0001104805,0.001628798],"genre_scores_gemma":[0.9916595,0.001407544,0.00124001,0.0008530294,0.0001647952,0.0005191886,0.002871572,0.00005264845,0.001231682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003552369,"threshold_uncertainty_score":0.01878691,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04460680893063991,"score_gpt":0.361642818466514,"score_spread":0.3170360095358741,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}